A
$ Value
$0
Shares
20,000
Price
$0
Filed
Mar 13
Insider
Name
FOLETTA MARK G
Title
—
CIK
0001236389
Roles
Director
Transaction Details
Transaction Date
2026-03-11
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,000
Footnotes
Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 11, 2026), with the final monthly installment vesting no later than the nearest trading day on the Nasdaq Global Select Market preceding the 2027 annual meeting of stockholders.
Filing Info
FOLETTA MARK G's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | ENTA | A | $0 |
| 2025-08-15 | DXCM | ▼ | $207K |
| 2025-08-15 | DXCM | ▼ | $16K |
| 2025-07-15 | DXCM | ▼ | $234K |
| 2025-07-15 | DXCM | ▼ | $688 |
| 2025-06-16 | DXCM | ▼ | $229K |
| 2025-05-08 | DXCM | G | $0 |
| 2025-05-08 | DXCM | G | $0 |
| 2025-05-08 | DXCM | A | $0 |
| 2025-05-02 | AMN | A | $0 |
Other Insiders at ENTA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER BRUCE L A | — | — | 2026-03-11 |
| Russell Lesley | — | — | 2026-03-11 |
| Peterson Kristine | — | — | 2026-03-11 |
|
Luly Jay R.
President and CEO
|
— | — | 2026-02-12 |
|
Or Yat Sun
Chief Scientific Officer
|
— | — | 2026-02-12 |
| Vance Terry | — | — | 2026-03-11 |
| Hata Yujiro S | — | — | 2026-03-11 |
|
Kowalsky Matthew Paul
Chief Legal Officer
|
— | — | 2026-02-12 |
|
Kieffer Tara Lynn
Chief Product Strategy Officer
|
— | — | 2026-02-12 |
|
Luu Brendan
Chief Business Officer
|
— | — | 2026-02-12 |
|
Rottinghaus Scott T.
Chief Medical Officer
|
— | — | 2026-02-12 |